Showing results (61-70 of 120) with videos related to

Sort By:
Pageof 12
Immunologic Research|January 1, 1992
IgG autoantibodies to C1q do not detectably influence complement activation in vivo and in vitro in systemic lupus erythematosusC E Siegert, M R Daha, S Lobatto, et al.
Clinical and Experimental Rheumatology|January 1, 1992
IgG and IgA autoantibodies to C1q in systemic and renal diseasesC E Siegert, M R Daha, C Halma, et al.
Arthritis Research & Therapy|April 17, 2019
Association between baseline clinical and imaging findings and the development of digital ulcers in patients with systemic sclerosisS Friedrich, S Lüders, A M Glimm, et al.
Scandinavian Journal of Immunology|April 1, 1995
Subclass distribution of IgA and IgG antibodies against Clq in patients with rheumatic diseasesI E Coremans, M R Daha, E A van der Voort, et al.
Clinical Immunology and Immunopathology|June 1, 1993
The relationship between serum titers of autoantibodies to C1q and age in the general population and in patients with systemic lupus erythematosusC E Siegert, M R Daha, A J Swaak, et al.
Arthritis Research & Therapy|January 26, 2019
Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: a DeSScipher/European Scleroderma Trials and Research group (EUSTAR) surveyJ Blagojevic, S Bellando-Randone, G Abignano, et al.
International Archives of Allergy and Immunology|January 1, 1994
Antiendothelial cell antibodies in systemic lupus erythematosus: enhanced antibody binding to interleukin-1-stimulated endotheliumJ M van der Zee, A M Miltenburg, C E Siegert, et al.
Journal of Clinical Immunology|July 20, 2007
Analyses of CD27++ plasma cells in peripheral blood from patients with bacterial infections and patients with serum antinuclear antibodiesEdwin Ten Boekel, Carl E Siegert, Gert-Jan Vrielink, et al.
Clinical and Experimental Immunology|May 1, 1991
Characterization of anti-endothelial cell antibodies in systemic lupus erythematosus (SLE)J M van der Zee, C E Siegert, T A de Vreede, et al.
Clinical Rheumatology|May 22, 2019
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher studyJelena Blagojevic, G Abignano, J Avouac, et al.
Pageof 12